RDC — Redcare Pharmacy NV Cashflow Statement
0.000.00%
- €2.64bn
- €2.74bn
- €2.37bn
- 50
- 23
- 76
- 46
Annual cashflow statement for Redcare Pharmacy NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.866 | -65.7 | -69.2 | -17.3 | -39 |
Depreciation | |||||
Non-Cash Items | 4.17 | 22 | 18 | 9.41 | 3.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.57 | 28.3 | -17.4 | 12 | -10.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 17.8 | 11.6 | -29.1 | 61.5 | 22.1 |
Capital Expenditures | -53.3 | -43.2 | -53.5 | -38.2 | -42.2 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 13.2 | -41.1 | -84.5 | -21.7 | 50.5 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -40.2 | -84.3 | -138 | -60 | 8.38 |
Financing Cash Flow Items | -13 | -6.38 | -7.07 | -8.02 | -8.97 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 50.2 | 230 | -13.5 | 15 | -17.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 27.8 | 157 | -181 | 17.4 | 12.7 |